The clinical pharmacology of short acting analgo-sedatives in neonates

Current Clinical Pharmacology

Volumn 6, Issue 4, 2011, Pages 222-226

  Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Developmental pharmacology; Ketamine; Midazolam; Neonate; Pharmacokinetics; Propofol; Remifentanil

Indexed keywords

CYTOCHROME P450 3A; ESTERASE; INHALATION ANESTHETIC AGENT; KETAMINE; MIDAZOLAM; PROPOFOL; REMIFENTANIL;

ANALGESIA; ANESTHESIA INDUCTION; APOPTOSIS; BLOOD PRESSURE; BRADYCARDIA; BRAIN HEMORRHAGE; CLINICAL PHARMACOLOGY; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG UPTAKE; ENDOTRACHEAL INTUBATION; ENZYME ACTIVITY; EXTUBATION; FUNCTIONAL RESIDUAL CAPACITY; HALLUCINATION; HEART OUTPUT; HEART RIGHT LEFT SHUNT; HUMAN; HYPERSALIVATION; HYPOTENSION; LARYNX SPASM; LASER SURGERY; LEUKOMALACIA; LUNG VENTILATION; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NERVE CELL LESION; NEWBORN APNEA; NEWBORN CARE; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NIGHTMARE; OXYGENATION; PEDIATRIC ANESTHESIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; SEDATION; STRIDOR; THORAX DISEASE; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 83455235349     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488411798375912     Document Type: Review

References (38)

1. Allegaert K, Veyckemans F, Tibboel D. Clinical practice: analgesia in neonates. Eur J Pediatr 2009; 168: 765-70.
2. Tibboel D, Anand KJ, van den Anker JN. The pharmacological treatment of neonatal pain. Semin Fetal Neonatal Med 2005; 10: 195-205.
3. Thewissen L, Allegaert K. Analgosedation in neonates: do we still need additional tools after 30 years of clinical research? Arch Dis Child Educ Pract Ed 2011; 96: 112-8.
4. Carbajal R, Lenclen R, Jugie M, et al. Morphine does not provide adequate analgesia for acute procedural pain amoung preterm neonates. Pediatrics 2005; 115: 1494-500.
5. de Wildt SN, Kearns GL, Hop WC, Murry DJ, et al. Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol 2002; 53: 390-2.
6. De Wildt SN, Kearns GL, Murry DJ, et al. Ontogeny of midazolam glucuronidation in preterm infants. Eur J Clin Pharmacol 2010; 66: 165-70.
7. Anderson BJ, Larsson P. A maturation model for midazolam clearance. Paediatr Anaesth 2011; 21: 302-8.
8. Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev 2003; CD002052.
9. Allegaert K. Is propofol the perfect hypnotic agent for procedural sedation in neonates? Curr Clin Pharmacol 2009; 4: 84-6.
10. Allegaert K, Peeters MY, Verbesselt R, et al.Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007; 99: 864-70.
11. Cockshott ID, Brigg LP, Douglas EJ, White M. Pharmacokinetics of propofol in female patients; Studies using single bolus injections. Br J Anaesth 1987; 59: 1103-10.
12. Peeters MY, Allegaert K, Blussé van Oud-Alblas HJ, et al. Prediction of propofol clearance in children from an allometric model de veloped in rats, children and adults versus a 0.75 fixed-exponent allometric model. Clin Pharmacokinet 2010; 49: 269-75.
13. Allegaert K, Peeters MY, Knibbe C. Propofol in (pre)term neonates: consider the extensive interindividual variability in clearance within the neonatal population. Paediatr Anaesth 2011; 21: 174-5.
14. Ghanta S, Abdel-Latif ME, Lui K, et al. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics 2007; 119: e1248-55.
15. Papoff P, Mancuso M, Caresta E, Moretti C. Effectiveness and safety of propofol in newborn infants. Pediatrics 2008; 121: 448-9.
16. Veyckemans F. Propofol for intubation of the newborn? Paediatr Anaesth 2001, 11: 630-1.
17. Vanderhaegen J, Naulaers G, Van Huffel S, et al. Cerebral and systemic hemodynamic effects of intravenous bolus administration of propofol in neonates. Neonatology 2010; 98:57-63.
18. Welzing L, Kribs A, Eifinger F, et al. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth 2010; 20: 605-11.
19. Shah PS, Shah VS. Propofol for procedural sedation/anaesthesia in neonates. Cochrane Database Syst Rev 2011; CD007548.
20. Penido MG, Garra R, Sammartino M, Pereira e Silva Y. Remifentanil in neonatal intensive care and anaesthesia practice. Acta Paediatr 2010; 99: 1454-63.
21. Welzing L, Ebenfeld S, Dlugay V, et al. Remifentanil degradation in umbilical cord blood of preterm infants. Anesthesiology 2011; 114: 570-7.
22. Anderson BJ, Pons G, Autret-Leca E, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth 2005; 15: 282-92.
23. Pereira e Silva Y, Gomez RS, Marcatto Jde O, et al. Morphine versus remifentanil for intubating preterm neonates. Arch Dis Child Fetal Neonatal Ed 2007; 92: F293-4.
24. Choong K, AlFaleh K, Doucette J, et al. Remifentanil for endotracheal intubation in neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2010; 95: F80-4.
25. Welzing L, Kribs A, Huenseler C, et al. Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Arch Dis Child Fetal Neonatal Ed 2007; 92: F293-4.
26. Sammartino M, Bocci MG, Ferro G, et al. Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: clinical experience. Paediatr Anaesth 2003; 13: 596-602.
27. Lago P, Tiozzo, Boccuzzo G, Allegro A, Zachello F. Remifentanil for percutaneous intravenous central catheter placement in preterm infant: a randomized controlled trial. Paediatr Anaesth 2008; 18: 736-44.
28. Anderson BJ, Allegaert K. The pharmacology of general anaesthetics in the neonate. Best Pract Res Clin Anaesthesiol 2010; 98: 932-9.
29. Michel F, Vialet R, Hassid S, et al. Sevoflurane for central catheter placement in neonatal intensive care: a randomized trial. Paediatr Anaesth 2010; 20: 712-9.
30. Hassid S, Nicaise C, Michel F, et al. Randomized controlled trial of sevoflurane for intubation in neonates. Paediatr Anaesth 2007; 17: 1053-8.
31. Davidson AJ. Anesthesia and neurotoxicity to the developing brain: the clinical relevance. Paediatr Anaesth 2011, doi: 10.1111/j.1460-9592.2010.03506.x
32. Brunette KE, Anderson BJH, Thomas J, et al. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures. Paediatr Anaesth 2011; 21: 653-62.
33. Saarenmaa E, Neuvonen PJ, Huttunen P, Fellman V. Ketamine for procedural pain relief in newborn infants. Arch Dis Child Fetal Neonatal Ed 2001; 85: F53-6.
34. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: from neonates to adolescents. Adv Drug Deliv Rev 2006; 58: 4-14.
35. Fanos V, Yurdakök M. Personalized neonatal medicine. J Matern Fetal Neonatal Med 2010; 23(Suppl 3): 4-6.
36. Allegaert K, Rochette A, Veyckemans F. Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance. Paediatr Anaesth 2011; 21: 266-73.
37. Lerman J, Heard C, Steward DJ. Neonatal tracheal intubation: an imbroglio unresolved. Paediatr Anaesth 2010; 20: 585-90.
38. Allegaert K, Naulaers G. Haemodynamics of intravenous paracetamol in neonates. Eur J Clin Pharmacol 2010; 66: 855-8.